Functional Alterations Due to COVID-19 Lung Lesions-Lessons From a Multicenter V/Q Scan-Based Registry.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Aug 2022
01 Aug 2022
Historique:
pubmed:
24
5
2022
medline:
12
7
2022
entrez:
23
5
2022
Statut:
ppublish
Résumé
In coronavirus disease 2019 (COVID-19) patients, clinical manifestations as well as chest CT lesions are variable. Lung scintigraphy allows to assess and compare the regional distribution of ventilation and perfusion throughout the lungs. Our main objective was to describe ventilation and perfusion injury by type of chest CT lesions of COVID-19 infection using V/Q SPECT/CT imaging. We explored a national registry including V/Q SPECT/CT performed during a proven acute SARS-CoV-2 infection. Chest CT findings of COVID-19 disease were classified in 3 elementary lesions: ground-glass opacities, crazy-paving (CP), and consolidation. For each type of chest CT lesions, a semiquantitative evaluation of ventilation and perfusion was visually performed using a 5-point scale score (0 = normal to 4 = absent function). V/Q SPECT/CT was performed in 145 patients recruited in 9 nuclear medicine departments. Parenchymal lesions were visible in 126 patients (86.9%). Ground-glass opacities were visible in 33 patients (22.8%) and were responsible for minimal perfusion impairment (perfusion score [mean ± SD], 0.9 ± 0.6) and moderate ventilation impairment (ventilation score, 1.7 ± 1); CP was visible in 43 patients (29.7%) and caused moderate perfusion impairment (2.1 ± 1.1) and moderate-to-severe ventilation impairment (2.5 ± 1.1); consolidation was visible in 89 patients (61.4%) and was associated with moderate perfusion impairment (2.1 ± 1) and severe ventilation impairment (3.0 ± 0.9). In COVID-19 patients assessed with V/Q SPECT/CT, a large proportion demonstrated parenchymal lung lesions on CT, responsible for ventilation and perfusion injury. COVID-19-related pulmonary lesions were, in order of frequency and functional impairment, consolidations, CP, and ground-glass opacity, with typically a reverse mismatched or matched pattern.
Identifiants
pubmed: 35605049
doi: 10.1097/RLU.0000000000004261
pii: 00003072-202208000-00028
pmc: PMC9275799
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e540-e547Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med . 2020;8:475–481.
Struyf T, Deeks J, Dinnes J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev . 2020;7:CD013665.
Afshar-Oromieh A, Prosch H, Schaefer-Prokop C, et al. A comprehensive review of imaging findings in COVID-19—status in early 2021. Eur J Nucl Med Mol Imaging . 2021;48:2500–2524.
Simpson S, Kay FU, Abbara S, et al. Radiological Society of North America Expert Consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging . 2020;2:e200152.
Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from non-Covid-19 viral pneumonia at chest CT. Radiology . 2020;296:E46–E54.
Ojha V, Mani A, Pandey NN, et al. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol . 2020;30:6129–6138.
Wang L, Ben S. Meta-analysis of chest CT features of patients with COVID-19 pneumonia. J Med Virol . 2021;93:241–249.
Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol . 2021;31:1–10.
Bajc M, Schümichen C, Grüning T, et al. EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond. Eur J Nucl Med Mol Imaging . 2019;46:2429–2451.
Cobes N, Guernou M, Lussato D, et al. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series. Eur J Nucl Med Mol Imaging . 2020;47:2453–2460.
Mahaletchumy T, Muhamad M, Mohammad Kazmin NE, et al. Pulmonary embolism in an asymptomatic COVID-19 patient detected on ventilation/perfusion SPECT/CT. Clin Nucl Med . 2021;46:e360–e362.
Goetz C, Fassbender TF, Meyer PT. Lung scintigraphy imaging features in a young patient with COVID-19. Clin Nucl Med . 2020;45:e523–e524.
Le Roux PY, Bonnefoy PB, Bahloul A, et al. Lung scintigraphy for pulmonary embolism diagnosis in COVID-19 patients: a multicenter study. J Nucl Med . 2021;jnumed.121.262955.
Chiarenza A, Esposto Ultimo L, Falsaperla D, et al. Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists. Insights Imaging . 2019;10:114.
Meyer G, Collignon MA, Guinet F, et al. Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism. Eur J Nucl Med . 1990;17:315–319.
Hu Q, Guan H, Sun Z, et al. Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan, China. Eur J Radiol . 2020;128:109017.
Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology . 2020;295:715–721.
Salehi S, Abedi A, Balakrishnan S, et al. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. Am J Roentgenol . 2020;215:87–93.
Calabrese F, Pezzuto F, Fortarezza F, et al. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European pulmonary pathologists. Virchows Arch . 2020;477:359–372.
Akbarialiabad H, Taghrir MH, Abdollahi A, et al. Long COVID, a comprehensive systematic scoping review. Infection . 2021;49:1163–1186.
Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J . 2016;37:67–119.
Bonnefoy PB, Margelidon-Cozzolino V, Catella-Chatron J, et al. What’s next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: from imaging finding to clinical consequences. Thromb Res . 2019;184:67–76.
Dhawan RT, Gopalan D, Howard L, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med . 2021;9:107–116.
Le Roux P-Y, Blanc-Béguin F, Bonnefoy P-B, et al. Guide pour la rédaction de protocoles pour la scintigraphie pulmonaire SFMN guideline for lung scintigraphy protocols. Médecine Nucléaire . 2021;45:85–92.